These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19849662)

  • 1. Thrombolysis for acute ischemic stroke.
    Uyttenboogaart M; De Keyser J; Luijckx GJ
    Curr Top Med Chem; 2009; 9(14):1285-90. PubMed ID: 19849662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic strategies for ischemic stroke in the thrombectomy era.
    Gauberti M; Martinez de Lizarrondo S; Vivien D
    J Thromb Haemost; 2021 Jul; 19(7):1618-1628. PubMed ID: 33834615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
    Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
    Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current acute stroke trials and their potential impact on the therapeutic time window.
    Schellinger PD; Köhrmann M
    Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
    Samaniego EA; Linfante I; Dabus G
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
    Ringleb PA; Schellinger PD; Schranz C; Hacke W
    Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
    Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
    Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical therapy for ischemic stroke: review of intravenous and intra-arterial treatment options.
    Taussky P; Tawk RG; Daugherty WP; Hanel RA
    World Neurosurg; 2011 Dec; 76(6 Suppl):S9-15. PubMed ID: 22182278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute ischemic stroke: Part I: recanalization strategies.
    Broderick JP; Hacke W
    Circulation; 2002 Sep; 106(12):1563-9. PubMed ID: 12234965
    [No Abstract]   [Full Text] [Related]  

  • 15. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current indications and results of thrombolysis by intravenous recombinant tissue plasminogen activator.
    Tari Capone F; Cavallari M; Casolla B; Orzi F
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):10-8. PubMed ID: 22464298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for acute ischemic stroke.
    Blakeley JO; Llinas RH
    J Neurol Sci; 2007 Oct; 261(1-2):55-62. PubMed ID: 17618652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis for acute ischemic stroke.
    Becker KJ
    Phys Med Rehabil Clin N Am; 1999 Nov; 10(4):773-85, vii. PubMed ID: 10573706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis in acute childhood stroke: design and challenges of the thrombolysis in pediatric stroke clinical trial.
    Amlie-Lefond C; Chan AK; Kirton A; deVeber G; Hovinga CA; Ichord R; Stephens D; Zaidat OO;
    Neuroepidemiology; 2009; 32(4):279-86. PubMed ID: 19223687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.